<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="566">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05153785</url>
  </required_header>
  <id_info>
    <org_study_id>Lidokain vid leverkirurgi</org_study_id>
    <secondary_id>2019-002361-35</secondary_id>
    <nct_id>NCT05153785</nct_id>
  </id_info>
  <brief_title>Perioperative Intravenous Lidocaine in Liver Surgery</brief_title>
  <official_title>Intravenous Lidocaine for Postoperative Recovery in Liver Surgery, a Randomized Double Blinded Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized double blinded placebo-controlled study, conducted in Lund, Sweden.&#xD;
      Patients will be randomized in two groups, with a ratio of 1:1. The experimental arm will&#xD;
      receive intravenous Lidocaine perioperatively, and the Control arm will receive placebo, i.e.&#xD;
      normal Saline. Postoperative both arms will get routine pain Control with PCA, Patient&#xD;
      Controlled Analgesia with an intravenous Oxycodone-infusion. Outcome-measures will include&#xD;
      patients pain intensity scoring, and opioid consumption.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patientes will be randozied in blocks of eight.&#xD;
&#xD;
      The experimental arm will receive a bolus of 1,5mg/kg before induction of anesthesia,&#xD;
      immediately followed by an infusion of 1,5mg/kg/h until 1 hour post surgery. The placebo arm&#xD;
      will receive the same amount of normal Saline instead. Pain intensity scoring, measured by&#xD;
      Numerical Rating Scale, NRS, will be conducted at 1, 2, 4 hour postoperatively, and each&#xD;
      morning and night until discharge, or for a maximum 5 Days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized double blinded placebo-controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption at 24 hours</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Sum of opioids consumed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption at 48 hours</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Sum of opioids consumed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption at 72 hours</measure>
    <time_frame>72 hours postoperatively</time_frame>
    <description>Sum of opioids consumed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption at 96 hours</measure>
    <time_frame>96 hours postoperatively</time_frame>
    <description>Sum of opioids consumed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption at 120 hours</measure>
    <time_frame>120 hours postoperatively</time_frame>
    <description>Sum of opioids consumed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain intensity</measure>
    <time_frame>Day 0-5 postoperatively, twice every day</time_frame>
    <description>Numerical rating scale (NRS) in rest and activity, scale 0-10, 0=no pain, 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Postoperative comlications</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Comparition of Complications classified according to Clavien Dindo, 0,1,2,3a,3b,4,5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Postoperative comlications</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Complications classified according to Clavien Dindo, 0,1,2,3a,3b,4a,4b,5, 0 beeing none and 5 beeng death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return of Bowel function</measure>
    <time_frame>Day 0-30 postoperatively</time_frame>
    <description>Time to first flatus and defacation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Postoperative nausea and vomiting</measure>
    <time_frame>Day 1-5 postopertively</time_frame>
    <description>Postoperative nausea and vomiting, as noted in questionary &quot;Quality of recovery-40&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Postoperative nausea and vomiting</measure>
    <time_frame>Day 1-5 postopertively</time_frame>
    <description>Postoperative nausea and vomiting, as noted in questionary &quot;Quality of recovery-40&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days in hospital</measure>
    <time_frame>0-90 days postoperatively</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of MEGX concentrations</measure>
    <time_frame>Twice during surgery, and once 1 hour after surgery.</time_frame>
    <description>Concentration of the metabolite &quot;MEGX&quot; in patients blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Lidocaine concentration</measure>
    <time_frame>Twice during surgery, and once 1 hour after surgery.</time_frame>
    <description>Concentration of Lidocaine in patients blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>death after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of Quality of recovery-40</measure>
    <time_frame>Day 1-5 postoperatively</time_frame>
    <description>Quality of recovery questionary.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant with Adverse Events</measure>
    <time_frame>0-30 days</time_frame>
    <description>All adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of adverse events</measure>
    <time_frame>0-30 days</time_frame>
    <description>All adverse events, classified according to CTCEA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Chronic Postsurgical pain</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Chronic Postsurgical pain, according to Brief Pain inventory- questionary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Chronic Postsurgical pain</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Chronic Postsurgical pain, according to Brief Pain inventory- questionary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Liver Metastases</condition>
  <condition>Liver Cancer</condition>
  <condition>Postoperative Pain</condition>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Lidocaine arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm will receive a bolus of 1,5mg/kg Lidocaine before induction of anesthesia, immediately followed by an infusion of 1,5mg/kg/h until 1 hour post surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo arm will receive the same amount of normal Saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Intravenous perioperative Lidocain for pain Control and improvement of postoperative recovery</description>
    <arm_group_label>Lidocaine arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 yy&#xD;
&#xD;
          -  Patient planned for minor hepatectomy&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Cirrosis&#xD;
&#xD;
          -  ASA&gt;3&#xD;
&#xD;
          -  Elevated liver enzymes&#xD;
&#xD;
          -  AV-block &gt;1, without pacemaker&#xD;
&#xD;
          -  WHO class &gt;2&#xD;
&#xD;
          -  Allergy against Lidocain or other amid-type local anasthesia&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Treatment with class III anti-arythimic medication&#xD;
&#xD;
          -  Preoperative ongoing opioid usage&#xD;
&#xD;
          -  Use of : Erythromycin, clarithromycin, Fluvoxamine, Cimetidine, ciprofloxacin,&#xD;
             antivirala-HIV-läkemedel or imidazol the week before surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bobby Tingstedt, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Lund University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emil Östrand, MD</last_name>
    <phone>+46-(0)46-171000</phone>
    <email>emil.ostrand@skane.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bobby Tingstedt, Prof</last_name>
    <phone>+46-(0)46-171000</phone>
    <email>bobby.tingstedt@skane.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Skåne University Hospital of Lund</name>
      <address>
        <city>Lund</city>
        <state>Skåne</state>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emil Östrand, MD</last_name>
      <phone>+46-46-171000</phone>
      <email>emil.ostrand@med.lu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Sun Y, Li T, Wang N, Yun Y, Gan TJ. Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2012 Nov;55(11):1183-94. doi: 10.1097/DCR.0b013e318259bcd8. Erratum in: Dis Colon Rectum. 2013 Feb;52(2):271.</citation>
    <PMID>23044681</PMID>
  </reference>
  <reference>
    <citation>Marret E, Rolin M, Beaussier M, Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008 Nov;95(11):1331-8. doi: 10.1002/bjs.6375. Review.</citation>
    <PMID>18844267</PMID>
  </reference>
  <reference>
    <citation>Vigneault L, Turgeon AF, Côté D, Lauzier F, Zarychanski R, Moore L, McIntyre LA, Nicole PC, Fergusson DA. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011 Jan;58(1):22-37. doi: 10.1007/s12630-010-9407-0. Review.</citation>
    <PMID>21061107</PMID>
  </reference>
  <reference>
    <citation>McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010 Jun 18;70(9):1149-63. doi: 10.2165/10898560-000000000-00000. Review.</citation>
    <PMID>20518581</PMID>
  </reference>
  <reference>
    <citation>Weibel S, Jelting Y, Pace NL, Helf A, Eberhart LH, Hahnenkamp K, Hollmann MW, Poepping DM, Schnabel A, Kranke P. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults. Cochrane Database Syst Rev. 2018 Jun 4;6:CD009642. doi: 10.1002/14651858.CD009642.pub3. Review.</citation>
    <PMID>29864216</PMID>
  </reference>
  <reference>
    <citation>Kranke P, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, Poepping DM, Weibel S. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015 Jul 16;(7):CD009642. doi: 10.1002/14651858.CD009642.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Jun 04;6:CD009642.</citation>
    <PMID>26184397</PMID>
  </reference>
  <reference>
    <citation>Dunn LK, Durieux ME. Perioperative Use of Intravenous Lidocaine. Anesthesiology. 2017 Apr;126(4):729-737. doi: 10.1097/ALN.0000000000001527. Review.</citation>
    <PMID>28114177</PMID>
  </reference>
  <reference>
    <citation>Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov;109(5):1464-9. doi: 10.1213/ANE.0b013e3181bab1bd.</citation>
    <PMID>19843784</PMID>
  </reference>
  <reference>
    <citation>Ortiz MP, Godoy MC, Schlosser RS, Ortiz RP, Godoy JP, Santiago ES, Rigo FK, Beck V, Duarte T, Duarte MM, Menezes MS. Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial. J Clin Anesth. 2016 Dec;35:70-77. doi: 10.1016/j.jclinane.2016.07.021. Epub 2016 Aug 6.</citation>
    <PMID>27871598</PMID>
  </reference>
  <reference>
    <citation>Sridhar P, Sistla SC, Ali SM, Karthikeyan VS, Badhe AS, Ananthanarayanan PH. Effect of intravenous lignocaine on perioperative stress response and post-surgical ileus in elective open abdominal surgeries: a double-blind randomized controlled trial. ANZ J Surg. 2015 Jun;85(6):425-9. doi: 10.1111/ans.12783. Epub 2014 Jul 31.</citation>
    <PMID>25078385</PMID>
  </reference>
  <reference>
    <citation>Kuo CP, Jao SW, Chen KM, Wong CS, Yeh CC, Sheen MJ, Wu CT. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth. 2006 Nov;97(5):640-6. Epub 2006 Sep 4.</citation>
    <PMID>16952918</PMID>
  </reference>
  <reference>
    <citation>Moore PA, Hersh EV. Local anesthetics: pharmacology and toxicity. Dent Clin North Am. 2010 Oct;54(4):587-99. doi: 10.1016/j.cden.2010.06.015. Review.</citation>
    <PMID>20831923</PMID>
  </reference>
  <reference>
    <citation>Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):564-75; discussion 524. Review.</citation>
    <PMID>15635516</PMID>
  </reference>
  <reference>
    <citation>Cassuto J, Wallin G, Högström S, Faxén A, Rimbäck G. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg. 1985 Oct;64(10):971-4.</citation>
    <PMID>3898920</PMID>
  </reference>
  <reference>
    <citation>Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004 Apr;98(4):1050-1055. doi: 10.1213/01.ANE.0000104582.71710.EE.</citation>
    <PMID>15041597</PMID>
  </reference>
  <reference>
    <citation>Herroeder S, Pecher S, Schönherr ME, Kaulitz G, Hahnenkamp K, Friess H, Böttiger BW, Bauer H, Dijkgraaf MG, Durieux ME, Hollmann MW. Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg. 2007 Aug;246(2):192-200. Erratum in: Ann Surg. 2009 Apr;249(4):701. Dijkgraaf, Omarcel G W [corrected to Dijkgraaf, Marcel G W].</citation>
    <PMID>17667496</PMID>
  </reference>
  <reference>
    <citation>Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6.</citation>
    <PMID>17197840</PMID>
  </reference>
  <reference>
    <citation>Martin F, Cherif K, Gentili ME, Enel D, Abe E, Alvarez JC, Mazoit JX, Chauvin M, Bouhassira D, Fletcher D. Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology. 2008 Jul;109(1):118-23. doi: 10.1097/ALN.0b013e31817b5a9b.</citation>
    <PMID>18580181</PMID>
  </reference>
  <reference>
    <citation>Striebel HW, Klettke U. [Is intravenous lidocaine infusion suitable for postoperative pain management?]. Schmerz. 1992 Dec;6(4):245-50. German.</citation>
    <PMID>18415635</PMID>
  </reference>
  <reference>
    <citation>Usubiaga JE, Wikinski J, Ferrero R, Usubiaga LE, Wikinski R. Local anesthetic-induced convulsions in man--an electroencephalographic study. Anesth Analg. 1966 Sep-Oct;45(5):611-20.</citation>
    <PMID>5950380</PMID>
  </reference>
  <reference>
    <citation>Drayer DE, Lorenzo B, Werns S, Reidenberg MM. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther. 1983 Jul;34(1):14-22.</citation>
    <PMID>6861434</PMID>
  </reference>
  <reference>
    <citation>DeToledo JC. Lidocaine and seizures. Ther Drug Monit. 2000 Jun;22(3):320-2. Review.</citation>
    <PMID>10850400</PMID>
  </reference>
  <reference>
    <citation>Beaussier M, Delbos A, Maurice-Szamburski A, Ecoffey C, Mercadal L. Perioperative Use of Intravenous Lidocaine. Drugs. 2018 Aug;78(12):1229-1246. doi: 10.1007/s40265-018-0955-x. Review.</citation>
    <PMID>30117019</PMID>
  </reference>
  <reference>
    <citation>Rimbäck G, Cassuto J, Tollesson PO. Treatment of postoperative paralytic ileus by intravenous lidocaine infusion. Anesth Analg. 1990 Apr;70(4):414-9.</citation>
    <PMID>2316883</PMID>
  </reference>
  <reference>
    <citation>Wallin G, Cassuto J, Högström S, Lindén I, Faxén A, Rimbäck G, Hedner T. Effects of lidocaine infusion on the sympathetic response to abdominal surgery. Anesth Analg. 1987 Oct;66(10):1008-13.</citation>
    <PMID>3631561</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Duncan K, Fitzgerald P, Nader A, Gould RW, McCarthy RJ. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014 Feb;24(2):212-8. doi: 10.1007/s11695-013-1077-x.</citation>
    <PMID>24036842</PMID>
  </reference>
  <reference>
    <citation>Dale GJ, Phillips S, Falk GL. The analgesic efficacy of intravenous lidocaine infusion after laparoscopic fundoplication: a prospective, randomized, double-blind, placebo-controlled trial. Local Reg Anesth. 2016 Dec 2;9:87-93. eCollection 2016.</citation>
    <PMID>27980437</PMID>
  </reference>
  <reference>
    <citation>Baral BK, Bhattarai BK, Rahman TR, Singh SN, Regmi R. Perioperative intravenous lidocaine infusion on postoperative pain relief in patients undergoing upper abdominal surgery. Nepal Med Coll J. 2010 Dec;12(4):215-20.</citation>
    <PMID>21744761</PMID>
  </reference>
  <reference>
    <citation>Yon JH, Choi GJ, Kang H, Park JM, Yang HS. Intraoperative systemic lidocaine for pre-emptive analgesics in subtotal gastrectomy: a prospective, randomized, double-blind, placebo-controlled study. Can J Surg. 2014 Jun;57(3):175-82.</citation>
    <PMID>24869609</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>November 29, 2021</last_update_submitted>
  <last_update_submitted_qc>November 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver surgery</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>opioid use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After publication, for 10 years.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

